Jim Simons
RPRX

Jim Simons’s Repros Therapeutics Inc. RPRX Stock Holding History

Jim Simons’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-794,913
Closed -$525K – 3780
2017
Q4 		$525K Sell
794,913
-327,100
-29% -$165K ﹤0.01% 2876
2017
Q3 		$359K Buy
1,122,013
+166,000
+17% +$58.2K ﹤0.01% 2867
2017
Q2 		$440K Buy
956,013
+228,900
+31% +$166K ﹤0.01% 2796
2017
Q1 		$873K Buy
727,113
+10,700
+1% +$13.4K ﹤0.01% 2590
2016
Q4 		$946K Buy
716,413
+49,300
+7% +$85.7K ﹤0.01% 2559
2016
Q3 		$1.39M Buy
667,113
+105,400
+19% +$208K ﹤0.01% 2404
2016
Q2 		$904K Buy
561,713
+384,000
+216% +$737K ﹤0.01% 2579
2016
Q1 		$172K Buy
177,713
+143,800
+424% +$140K ﹤0.01% 3125
2015
Q4 		$41K Sell
33,913
-10,987
-24% -$35.3K ﹤0.01% 3194
2015
Q3 		$334K Sell
44,900
-157,243
-78% -$1.2M ﹤0.01% 2735
2015
Q2 		$1.45M Buy
+202,143
New +$1.57M ﹤0.01% 2262

Jim Simons's RPRX Position: Q1 2018 in Review

Jim Simons sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 794,913 shares — an estimated $525K sold.

Jim Simons first reported a position in RPRX in Q2 2015 and held it in 11 quarters. The position peaked at $1.45M in Q2 2015. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Jim Simons reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Jim Simons sold 794,913 Repros Therapeutics Inc. shares in Q1 2018, an estimated $525K.
  • Jim Simons first reported a position in Repros Therapeutics Inc. in Q2 2015 and held it in 11 quarters.
  • Jim Simons's Repros Therapeutics Inc. position peaked at $1.45M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.